CYNTHIA PLANEAUX: Open Payments
NPI 1972569283 · TAYLOR MILL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,163 in 91 payments from 21 companies in 2025. Trend: 2023 $2,438 · 2024 $2,251 · 2025 $3,163
Food & beverage: $3,163
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $656 |
| ABBVIE INC. | 19 | $605 |
| Novo Nordisk Inc | 16 | $468 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $204 |
| Axsome Therapeutics, Inc. | 4 | $168 |
| Lilly USA, LLC | 6 | $155 |
| Dexcom, Inc. | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 1 | $122 |
| PFIZER INC. | 6 | $100 |
Products named: VRAYLAR, Wegovy, BREZTRI, AIRSUPRA, Kerendia, UBRELVY, Symbravo, DEXCOM G7 GSS (161).
Industry payments across KY — which companies pay providers there.
